login
  Password reminder
NeuroNews
Contact the editor Visit NeuroNews Twitter feed Visit NeuroNews Facebook page
 
Tuesday, 19 May 2015
The Enroute transcarotid stent is the first carotid stent that is introduced and implanted into the carotid artery through a direct common carotid access point to enable a safe and more direct approach to carotid artery stenting. FDA grants premarket approval for Enroute transcarotid stent system

Prodigy SCS approved and first implanted in Canada
Tuesday, 19 May 2015
The Prodigy system is the only implantable spinal cord stimulation (SCS) system approved to deliver St Jude Medical’s proprietary burst stimulation as well as traditional SCS to reduce pain, improve patient satisfaction and eliminate paraesthesia in some patients. Prodigy SCS approved and first implanted in Canada

More news

VIDEOS

Neuroprosthetics for paralysis: a new implant on the spinal cord

New therapies are on the horizon for individuals paralysed following spinal cord injury. The e-Dura implant developed by EPFL scientists can be applied directly to the spinal cord without causing damage and inflammation.

More videos

PROFILES

Robert E Harbaugh
Thursday, 14 May 2015
Robert E Harbaugh speaks to NeuroNews about how far neurosurgery has come, and as president of AANS ... Robert E Harbaugh

More profiles

Geoffrey Colby and Alexander Coon

Radiation reduced with flow diversion

New research shows that treatment of large and giant proximal internal carotid artery aneurysms with flow diversion requires less radiation, less fluoroscopy time, and less contrast administration than standard coiling techniques.

OPINION

EVENTS

New day in acute ischaemic stroke therapy The newest generation of trials for acute ischaemic stroke, including MR CLEAN, ESCAPE, EXTEND IA and SWIFT PRIME, appear to have ushered in a new era in stroke therapy. Now, Joseph Broderick (... New day in acute ischaemic stroke therapy

Flow diverter technology for intracranial aneurysms Gabor Toth writes for NeuroNews about the flow diverters that are currently available and the ongoing clinical trials that could have the potential to extend the indications of flow diverter therapy ... Flow diverter technology for intracranial aneurysms







Medina coil
Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions